Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: "Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

  • August 26, 2025

Share

  • 1

    The article addresses corrections to authorship and funding in a previous publication.

  • 2

    Benaya Rozen-Zvi's name was corrected to include a hyphen in the authorship roster.

  • 3

    Anat Gafter-Gvili's name was also corrected to include a hyphen in the authorship roster.

  • 4

    The funding section was updated to reflect the correct spelling of Benaya Rozen-Zvi's name.

  • 5

    The corrections have been made available online for the referenced article.

Original Source(s)

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

Related Content

Self-Reported Adverse Effects Among Social Media Users Taking Nonapproved Retatrutide

Error in Results, Figure, and Table

  • October 28, 2026

Cryptococcal cellulitis may lead to amputation

A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.